Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT03868241 Completed - Critically Ill Clinical Trials

Coated Devices to Decrease Infection in the Intensive Care Unit

CRITIC
Start date: April 6, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Pilot explanatory, randomized, open label, controlled trial. Critically ill patients which will demand placement of invasive devices for organ support (endotracheal tube, central venous catheter and urinary Foley catheter) will be randomized 1:1 to receive coated (Bactiguard®) or habitual (non-coated) devices.

NCT ID: NCT03865966 Recruiting - Clinical trials for Hepatitis B Infection

Hepatitis B Virus Infection After Liver Transplantation in Children

Start date: July 5, 2019
Phase:
Study type: Observational

China is a highly prevalent area of hepatitis B virus(HBV) infection, with at least 75 million hepatitis B virus carriers, and 80% of primary hepatocellular carcinoma (HCC) is associated with chronic hepatitis B virus infection. Liver transplantation is currently the preferred method for end-stage liver disease such as biliary atresia and cirrhosis in children. In recent years, children's liver transplantation has developed rapidly and the number of developments has increased significantly. If there is chronic hepatitis B virus infection in the donor liver, it may cause HBV transmission, or the patient may have a low-load occult hepatitis B virus infection, and after immunosuppressive treatment, it may lead to hepatitis B virus infection after surgery.

NCT ID: NCT03864952 Recruiting - Infection Clinical Trials

Infectious Agents Exposure : Archiving in Dental Plaque

DIAS
Start date: March 4, 2019
Phase:
Study type: Observational

We are studying the possibility of using dental calculus as a reservoir for the genes of an infectious agent that has infected the patient in previous months; as it is done to highlight climate change in ice samples.

NCT ID: NCT03864263 Recruiting - Clinical trials for Hepatitis b Virus Infection

Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents

Start date: July 4, 2019
Phase:
Study type: Observational

Hepatitis B virus (HBV) infection is a major public health problem facing the world, with more than 2 billion people infected with HBV. There are more than 400 million chronic carriers, and 75% of carriers live in the Asia Pacific region. The mother-to-child transmission route of hepatitis B virus is recognized as one of the most important routes of transmission, and recent studies have found that fathers who are carriers of HBV may also be one of the risk factors for HBV infection in children, but as far as the investigators know. Therefore, as a high-population area in China, the purpose of this study is to investigate the prevalence of HBV infection in this population.

NCT ID: NCT03859375 Completed - Clinical trials for Surgical Site Infection

Number of Necessary Paints of Preoperative Skin Disinfection to Prevent Surgical Site Infections

PAINTS
Start date: January 29, 2019
Phase:
Study type: Observational

This observational study investigates whether 3 paints are superior compared to 2 paints in reducing microbial skin counts in the disinfection area of cardiac and abdominal surgery patients.

NCT ID: NCT03858907 Recruiting - Clinical trials for Cytomegalovirus Infections

Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV

Start date: August 5, 2018
Phase:
Study type: Observational

To evaluate the Quantiferon-CMV test ability to predict occurrence of cytomegalovirus (CMV) disease o treated infection after kidney transplantation. Patients studied are those already infected by CMV before transplantation ("seropositive"). Patients given thymoglobulin as induction therapy receive CMV prophylaxis with valganciclovir, while those given basiliximab undergo weekly monitoring for CMV viremia with preemptive treatment as needed.

NCT ID: NCT03857295 Not yet recruiting - Clinical trials for Bacterial Infections

Infections Following NeuroSurgery (INS)

INS
Start date: March 11, 2019
Phase:
Study type: Observational

Neurosurgery (NS) is essential for the treatment of various diseases such as malignant tumors, vascular conditions, spinal stenosis or trauma. However, NS can be complicated by the onset of infections, directly related to surgery or to hospitalization. Little is known regarding the epidemiology, the optimal treatment regimens and the outcome of infections following NS (I-NS). The study aims at investigating the clinical and microbiological characteristics as well as the outcomes of I-NS occurring at a single Institution (IRCCS Neuromed, Pozzilli, Italy) during the period 2016-2018. Patients with at least 1 infective episode requiring antimicrobial therapy are included in this retrospective observational study.

NCT ID: NCT03856138 Completed - Clinical trials for Inflammatory Response

Effect of Gut Microbiota and Fecal Inflammatory Marker on Childhood Gastroenteritis

Start date: December 1, 2015
Phase:
Study type: Observational

Childhood gastroenteritis establishes gastrointestinal disease and increase the economic burden, and the pediatric population is especially vulnerable to these gastrointestinal infections. The aim of this study is to evaluate the role of intestinal microbiota and their relationship with childhood gastroenteritis.

NCT ID: NCT03855709 Not yet recruiting - Clinical trials for Antibiotic Resistant Infection

Antibiotic-resistant Bacterial Infection of Hepatic Patients

Start date: May 2019
Phase:
Study type: Observational

the investigators want to identify the microbial profile, antibiotic resistant bacteria in hepatic patients with infections in Liver ICU, and explore risk factors and outcomes in those patients with antibiotic resistant bacteria.

NCT ID: NCT03854695 Withdrawn - Diabetic Foot Ulcer Clinical Trials

Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection

Start date: February 1, 2019
Phase:
Study type: Observational

The investigators plan to enroll up to 750 subjects over the course of 5 years. Study duration will be 2 visits over 7 days (+/-3). Participants will be consented and undergo baseline procedures. Participants will be grouped into 1 of 3 groups, based on infection and antibiotic status at screening. Debridement will be performed per standard of care and collection of tissue will be taken from this discarded tissue. A blood draw will be performed at each of these two visits as well. This is for research purposes only. All other data will be obtained from the electronic medical record. All standard of care except for the blood draws.